1. Home
  2. NTRA vs ERIE Comparison

NTRA vs ERIE Comparison

Compare NTRA & ERIE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • ERIE
  • Stock Information
  • Founded
  • NTRA 2003
  • ERIE 1925
  • Country
  • NTRA United States
  • ERIE United States
  • Employees
  • NTRA N/A
  • ERIE N/A
  • Industry
  • NTRA Medical Specialities
  • ERIE Specialty Insurers
  • Sector
  • NTRA Health Care
  • ERIE Finance
  • Exchange
  • NTRA Nasdaq
  • ERIE Nasdaq
  • Market Cap
  • NTRA 21.9B
  • ERIE 17.9B
  • IPO Year
  • NTRA 2015
  • ERIE 1995
  • Fundamental
  • Price
  • NTRA $138.90
  • ERIE $355.70
  • Analyst Decision
  • NTRA Strong Buy
  • ERIE
  • Analyst Count
  • NTRA 16
  • ERIE 0
  • Target Price
  • NTRA $185.56
  • ERIE N/A
  • AVG Volume (30 Days)
  • NTRA 1.3M
  • ERIE 144.8K
  • Earning Date
  • NTRA 08-07-2025
  • ERIE 08-05-2025
  • Dividend Yield
  • NTRA N/A
  • ERIE 1.53%
  • EPS Growth
  • NTRA N/A
  • ERIE 26.84
  • EPS
  • NTRA N/A
  • ERIE 11.75
  • Revenue
  • NTRA $1,831,000,000.00
  • ERIE $3,903,813,000.00
  • Revenue This Year
  • NTRA $19.75
  • ERIE $11.70
  • Revenue Next Year
  • NTRA $16.04
  • ERIE $7.83
  • P/E Ratio
  • NTRA N/A
  • ERIE $30.34
  • Revenue Growth
  • NTRA 51.50
  • ERIE 14.91
  • 52 Week Low
  • NTRA $92.14
  • ERIE $332.34
  • 52 Week High
  • NTRA $183.00
  • ERIE $547.00
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 30.96
  • ERIE 51.56
  • Support Level
  • NTRA $136.91
  • ERIE $341.76
  • Resistance Level
  • NTRA $142.49
  • ERIE $367.65
  • Average True Range (ATR)
  • NTRA 5.08
  • ERIE 8.63
  • MACD
  • NTRA -1.82
  • ERIE 2.32
  • Stochastic Oscillator
  • NTRA 7.18
  • ERIE 51.19

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About ERIE Erie Indemnity Company

Erie Indemnity Co mainly performs services on behalf of the Erie Insurance Exchange relating to sales, underwriting, and issuance of policies. Erie Indemnity's results are tied to the performance of the Insurance Exchange, which principally provides automobile and homeowners insurance for individuals, along with multiperil, workers' compensation, and commercial automobile insurance for its commercial clients. The company operates exclusively in the United States.

Share on Social Networks: